Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
NORETHISTERONE
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
G03DC02
5 mg
TABLET
NORETHISTERONE 5 mg
ORAL
Prescription Only
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
ACTIVE
1990-06-22
Checked by: Phoebe Date: 04/05/2011 PROPOSED PACKAGE INSERT SUNOLUT TABLET Each tablet contains:- Norethisterone 5 mg THERAPEUTIC PROPERTIES: Norethisterone transforms poliferative endometrium into secretary endometrium. It inhibits the secretion of pituitary gonadotropins, which in turn prevents follicular maturation and ovulation. ADVERSE EFFECTS: 1. Breakthrough bleeding 2. Spotting 3. Change in menstrual flow 4. Amenorrhea 5. Oedema 6. Changes in weight 7. Changes in cervical mucous and cervical secretion 8. Cholestatic jaundice 9. Rash (allergic) with and without pruritus 10. Melasma or chloasma 11. Mental depression 12. Nausea 13. Headache 14. Visual disturbances CONTRAINDICATIONS: 1. Thrombophlebitis, thromboembolic disorders, cerebral apoplexy or patients with a past history of these conditions. 2. Known or suspected carcinoma of the breast. 3. Undiagnosed vaginal bleeding. 4. Missed abortion. 5. As a diagnostic test for pregnancy. USAGE DURING PREGNANCY AND LACTATION: It should be avoided during pregnancy and by nursing mothers. DOSAGE: This dosage schedule assumes the interval between menses to be 28 days. Amenorrhea, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology: 5 to 20 mg norethisterone starting with the fifth day of the menstrual cycle and ending on the 25 th day. Endometriosis: Initial daily dosage of 10mg norethisterone for two weeks with increments of 5 mg per day of norethisterone every two weeks until 30 mg per day of norethisterone is reached. Therapy may be held at this level for six to nine months or until annoying breakthrough bleeding demands temporary termination. INCOMPATIBILITIES: Reports of incompatibilities if any are not available. INTERACTIONS: The concomitant use of oestrogens with progestogens may rendered less effective and an increased incidence of breakthrough bleeding may occur by virtue of drug interaction with rifampicin, isoniazid, ampicillin, tetracycline, neomycin, penicillin, chloramphenicol, sulphonamides, nitrofurantoin, barbit Read the complete document